Results 51 to 60 of about 137,068 (205)

Nonalcoholic steatohepatitis pharmacotherapy and predictors of response: dual role of aminotransferases as biosensors of metabolism and biomarkers of histological improvement [PDF]

open access: yes, 2019
Nonalcoholic steatohepatitis (NASH)—the severe histological form of nonalcoholic fatty liver disease (NAFLD)—is regarded as a major health problem worldwide (1,2).
Pirola, Carlos José   +1 more
core   +1 more source

Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOME® trial [PDF]

open access: yes, 2018
Aims/hypothesis: In addition to beneficial effects on glycaemia and cardiovascular death, empagliflozin improves adiposity indices. We investigated the effect of empagliflozin on aminotransferases (correlates of liver fat) in individuals with type 2 ...
Fitchett, David   +4 more
core   +1 more source

Emerging Insights into the Role of BDNF on Health and Disease in Periphery

open access: yesBiomolecules
Brain-derived neurotrophic factor (BDNF) is a growth factor that promotes the survival and growth of developing neurons. It also enhances circuit formation to synaptic transmission for mature neurons in the brain.
Mayuko Ichimura-Shimizu   +5 more
doaj   +1 more source

A new non-invasive method for assessing steatosis in chronic liver diseases [PDF]

open access: yesТерапевтический архив, 2016
Aim. To assess the diagnostic accuracy of the controlled attenuation parameter (CAP) to determine the grade of hepatic steatosis (HS) in patients with chronic liver diseases (CLD) of different etiologies and to compare the obtained results with ...
I G Bakulin   +3 more
doaj  

Steatohepatitis in Children with Obesity

open access: yesВопросы современной педиатрии, 2021
The article discusses the issues of steatohepatitis development, diagnosis, and management in children. Steatohepatitis is one of the forms of non-alcoholic fatty liver disease diagnosed in 12–26% of children with obesity.
Alexander A. Zvyagin   +3 more
doaj   +1 more source

Deficiency of the purinergic receptor 2X7 attenuates nonalcoholic steatohepatitis induced by high-fat diet. possible role of the NLRP3 Inflammasome [PDF]

open access: yes, 2017
Molecular mechanisms driving transition from simple steatosis to nonalcoholic steatohepatitis (NASH), a critical step in the progression of nonalcoholic fatty liver disease (NAFLD) to cirrhosis, are poorly defined. This study aimed at investigating the
Blasetti Fantauzzi, Claudia   +6 more
core   +3 more sources

ST-segment elevation myocardial infarction in the presence of metabolic-associated fatty liver disease

open access: yesРоссийский кардиологический журнал, 2023
Aim. To assess the characteristics of ST-segment elevation myocardial infarction (STEMI) in patients with metabolic syndrome (MS) in the presence and absence of metabolic-associated fatty liver disease (MAFLD).Material and methods.
V. A. Tretyakova   +5 more
doaj   +1 more source

Role of High-Mobility Group Box-1 in Liver Pathogenesis [PDF]

open access: yes, 2019
High-mobility group box 1 (HMGB1) is a highly abundant DNA-binding protein that can relocate to the cytosol or undergo extracellular release during cellular stress or death. HMGB1 has a functional versatility depending on its cellular location.
Huda, Nazmul   +3 more
core   +1 more source

Liver transplantation for alcoholic cirrhosis: Long term follow-up and impact of disease recurrence [PDF]

open access: yes, 2001
Background. Alcoholic liver disease has emerged as a leading indication for hepatic transplantation, although it is a controversial use of resources. We aimed to examine all aspects of liver transplantation associated with alcohol abuse.
Andrea M. DiMartini   +71 more
core   +2 more sources

Sinusoidal cell–derived biomarker scores predict diagnosis and prognosis in chronic liver disease

open access: yesBMC Medicine
Background Sinusoidal cells are central drivers of chronic liver disease (CLD) progression, yet current biomarkers fail to capture their phenotypic states.
Sergi Guixé-Muntet   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy